
|Articles|April 14, 2008
Bendamustine approved by FDA for chronic lymphocytic leukemia
Bendamustine has been approved by the FDA for the treatment of CLL
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Enflonsia for the Prevention of RSV Lower Respiratory Tract Disease in Infants
2
Pharmacists Experience Challenges in Credentialing, Billing for Services | NCPA 2025
3
American Pharmacists Month: Pharmacies Expanding Clinical Services Amid Network, Access Challenges
4
Pharmacy Technology Should Focus on Patient Engagement, Peer Insight | NCPA 2025
5